FITC Plus Anti-Human HLA-DR (L243)
HLA-DR Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2a, kappa
Reactivity
Human and More (1)
Applications
FC
Conjugate
FITC Plus Fluorescent Dye
CloneNo.
L243
Cat no : FITC-65218
Synonyms
Validation Data Gallery
Filter:
Tested Applications
| Positive FC detected in | human PBMCs |
Recommended dilution
| Application | Dilution |
|---|---|
| This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| FC | See 2 publications below |
Product Information
FITC-65218 targets HLA-DR in FC applications and shows reactivity with Human samples.
| Tested Reactivity | Human |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgG2a, kappa |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen | Human lymphoblastoid B-cell line RPMI 8866 相同性解析による交差性が予測される生物種 |
| Full Name | major histocompatibility complex, class II, DR alpha |
| Calculated molecular weight | 254 aa, 29 kDa |
| GenBank accession number | BC032350 |
| Gene symbol | HLA-DRA |
| Gene ID (NCBI) | 3122 |
| Conjugate | FITC Plus Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 495 nm / 524 nm |
| Form | Liquid |
| Purification Method | Protein A purification |
| Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
| Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for FITC Plus HLA-DR antibody FITC-65218 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Cells Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer | ||
Front Immunol Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma |
